Nanobiotix names Arnd Christ CFO, succeeding Bart Van Rhijn

NBTX•2026-10-01

Nanobiotix named Arnd Christ chief financial officer, effective Oct. 1, 2026. Christ will join the executive board, while Bart Van Rhijn will step down after five years in the role.

1. CFO transition

Christ previously served as CFO of Nasdaq-listed Immatics from October 2020 to September 2025. Van Rhijn will also step down as head of business development.

Nanobiotix names Arnd Christ CFO, succeeding Bart Van Rhijn

1. CFO transition

Related News

RiverNorth/DoubleLine Strategic Opportunity Fund sets monthly distribution at $0.0910 per share

Onto Innovation director David Brian Miller disposes of 2,000 common shares for $600,000

Larimar Therapeutics president, COO John B. Harlow Jr. files initial beneficial ownership statement

Fed's Cook sees AI inflationary push as a top 2027 risk

Highland Global Allocation Fund declares $0.085 monthly distribution for October-December 2026